As supply chains grow increasingly complex, outsourcing to contract manufacturers helps companies meet consumer demand and financial performance goals. Multi-enterprise networks require technology to regain visibility and control.
Efficiently access data from all trading partners, quickly respond to challenges based on artificial intelligence (AI)-driven recommendations and collaborate with partners to resolve issues together. Building resiliency into your supply chain prepares you for disruptions.
The pharmaceutical industry has seen unprecedented disruptions. The fallout has included demand, supply and logistics shocks such as hoarding-induced artificial shortfalls, supply constraints on active ingredients and expedients, transportation disruptions, and port closures. In addition, global pharmaceutical supply chains are becoming increasingly complex as companies address pricing and regulatory pressures, shorter product lifecycles and time-to-market competition.
Challenges that Accompany the Benefits
To compete, pharmaceutical companies are reassessing their core competencies and identifying partners for outsourcing—such as contract manufacturers—at an increasing rate. With all the benefits of outsourcing comes the loss of visibility and control. When you add in major disruptions, it becomes clear that a connected supply chain ecosystem is essential. e2open helps address these concerns with technologies and applications supported by a connected business network, enabling you to efficiently access and analyze data and collaborate across your network to handle issues together with your partners.
Disruptions aren’t rare—they are expected. With e2open, you can anticipate them, prepare ahead of time and take action based on current, decision-grade data.
The Connected Pharmaceutical Supply Chain: Resilience and Agility
Hear from Pawan Joshi, e2open’s Executive Vice President of Product Management & Strategy, as he discusses today’s supply chain challenges and how technology can give pharmaceutical companies an edge.
Pharmaceutical and Life Science Manufacturing: Are You in Control?
Due to significant investments in outsourcing to contract manufacturers and other trading partners, pharmaceutical companies have justifiable concerns about losing control and lacking visibility into their supply chains.
Improve Accuracy, Quality and Agility
Leverage automation to enforce consistent quality standards across your entire end-to-end supply chain ecosystem—including contract manufacturers—for regulatory compliance, yield optimization and management of all quality processes.
Automation Connecting All Tiers of Supply
Now you can automate real-time information exchanges with and among partners. Effective collaboration helps you develop trust and confidence, leverage economies of scale and create a more agile, responsive and efficient supply network.